T
Thyme Care
Value-based oncology care for health plans and employers
About Thyme Care
Thyme Care is a US value-based oncology care company that works with health plans, employers and risk-bearing providers to improve the experience and outcomes of people living with cancer while reducing the total cost of their care. Founded in 2020 by Robin Shah and Dr. Bobby Green and based in Nashville, Tennessee, the company addresses the fragmented and confusing path patients face after a cancer diagnosis, where care is spread across oncologists, surgeons, hospitals and primary care physicians.
Its model combines a technology-enabled care team with close integration into oncology practices. Members get a single point of contact staffed by doctors, oncology nurses, social workers and care partners, who provide virtual support around the clock, help with appointments, transportation and symptom management, and intervene early to avoid emergency visits and hospital admissions. Electronic patient-reported outcome surveys let the team spot problems between visits, and palliative care and survivorship services are integrated into the program.
Behind the care team sits a purpose-built technology and data analytics platform that identifies at-risk patients, guides next steps and synthesizes complex clinical data, with artificial intelligence used to automate documentation and surface real-time insights for care teams. Thyme Care works with more than 1,000 oncologists nationwide, taking on administrative and coordination tasks so practices can focus on patient care and supporting higher-value treatment choices.
The company operates under value-based arrangements in which it shares accountability with payers and providers for quality, outcomes and cost, covering Medicare, commercial and employer-sponsored populations. Its offering is available to millions of people across the United States, and it has created Thyme Companies, a parent organization intended to build additional businesses addressing other parts of the cancer journey.
Source: Dealroom company dataOpen roles
| Role | Team | Location | Posted |
|---|---|---|---|
| Senior Platform EngineerEngineering | Engineering | Mission, US | yesterday |
| VP, Data | Mission, US +1 | yesterday | |
| Medical Director, Palliative CareClinical | Clinical | New York, US | yesterday |
| Senior Medical Director, OncologyClinical | Clinical | Mission, US | yesterday |
| Enrollment Specialist - Bi-lingual | Lea Avenue, US | 1w ago | |
| Enrollment Specialist | Lea Avenue, US | 1w ago | |
| Licensing & Credentialing CoordinatorOperations | Operations | New York, US | 3w ago |
| Senior Associate, Payer Growth Strategy and OperationsOperations | Operations | Mission, US +1 | 3w ago |
| Strategic Initiatives Lead, Consumer AI | Mission, US | 3w ago | |
| Complex Care PhysicianClinical | Clinical | Lea Avenue, US | 1mo ago |
| Director/Principal Research Scientist, Health EconomicsData & AI | Data & AI | Mission, US | 1mo ago |
| Oncology Triage Nurse (8:30AM - 5PM EST Shift)Clinical | Clinical | Lea Avenue, US | 1mo ago |
Thyme Care in the Nashville ecosystem
The Thyme Care office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Andreessen Horowitz
Frist Cressey Ventures
AlleyCorp
Casdin Capital
Bessemer Venture Partners
Foresite Capital
Town Hall Ventures
Series B and later8 investors entered at this stage
Echo Health Ventures
CVS Health Ventures
Banc of California
Concord Health Partners
Morgan Health
Texas Oncology Physicians Association
Humana
Memorial Hermann Health System
Source: Dealroom Talent Intelligence.
See Thyme Care on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
Thyme Care raises $125M Series E at $2B valuation, launches oncology holding company